Founded in 1978 by Kiran Mazumdar-Shaw, Biocon Ltd. is an Indian biopharmaceutical company headquartered in Bangalore. The company's core mission is to enhance global healthcare through innovative and affordable biopharmaceuticals. Biocon's product portfolio includes statins, immunosuppressants, and anti-diabetic drugs, alongside specialty enzymes and custom research services. The firm also offers clinical research services, focusing on the development of novel enzyme applications and biopharmaceuticals to address unmet medical needs.
Notable figures associated with Biocon include its founder Kiran Mazumdar-Shaw, a pioneering entrepreneur in biotechnology. The company has attracted significant investment and partnerships from global pharmaceutical giants. Key achievements include the successful launch of biosimilars in international markets and the establishment of a robust pipeline of biopharmaceuticals. Biocon's impact is evident in its contribution to making critical therapies more accessible and affordable, thereby improving patient outcomes worldwide.
